Researchers Design First Artificial Ribosome
Researchers at Northwestern and the University of Illinois at Chicago have engineered an artificial ribosome, which may enable the production of new drugs and next-generation biomaterials.
Researchers at Northwestern and the University of Illinois at Chicago have engineered an artificial ribosome, which may enable the production of new drugs and next-generation biomaterials.
The national award honors young faculty members in the chemical sciences who demonstrate leadership in research and education.
A team of Northwestern researchers developed a new computational model that elucidates the dynamic interplay between cancer and the immune system.
Keith Tyo is one of five McCormick faculty members to have received a prestigious Faculty Early Career Development (CAREER) Award from the National Science Foundation.
By replacing highly specialized, expensive equipment with standard lab tools, Michael Jewett has made synthetic biology research cheaper, faster, and more accessible.
With such ambitious goals as helping cure cancer and eradicating
pervasive disease, some of the most talented scientists in the
country from the emerging field of synthetic biology are breaking
new ground at Northwestern University.
Synthetic biologist Joshua Leonard and his team have developed a technology for engineering human cells as therapies that become activated only in diseased tissues.
With such ambitious goals as helping cure cancer and eradicating pervasive disease, a group of scientists from the emerging field of synthetic biology are breaking new ground at Northwestern University.
Some of the leading minds in synthetic biology assembled in Chicago last month for an international synthetic biology workshop, co-hosted by Northwestern University and the UK Science and Innovation Network.
Northwestern synthetic biology researchers, working with partners at Harvard Medical School, have for the first time synthesized protein-generating cell structures called ribosomes in a test tube.